  Diabetic-induced peripheral neuropathy (DPN) is a diabetic late complication.
The molecular mechanisms underlying the pathophysiology of nerve damage &
sensory loss remain largely unclear. Recently, alterations in metabolic flux
have gained attention a basis for organ damage in diabetes; however, peripheral
sensory neurons have not been adequately analyzed. In the present study, we
attempted to delineate the role of alteration of metabolic pathways in relation
to nerve damage & sensory loss. We employed STZ-injected mouse model of type1
diabetes. To investigate the progression of DPN by behavioral measurements of
sensitivity to thermal & mechanical stimuli and quantitative assessment of
intraepidermal nerve fiber density. We employed a MS-based screen to address
alterations in levels of metabolites in peripheral sciatic nerve (SN) & amino
acids (AA) in serum over several months post-STZ administration. Although
hyperglycemia & body weight changes occurred early, sensory loss & reduced
intraepithelial branching of nociceptive nerves was only evident at 22 wks
post-STZ. The longitudinal metabolites screen in SN demonstrated that mice at
12 and 22 wks post-STZ showed an early impairment the tricarboxylic acid. We
found that levels of citric acid, ketoglutaric acid, succinic acid, fumaric
acid & malic acid were observed to be significantly reduced in SN at 22 wks
post-STZ. In addition, we also found the increase in levels of sorbitol &
L-Lactate in SN from 12 wks post-STZ injection. AA screen in serum showed that
the amino acids Val, Ile and Leu, increased more than 2-fold from 12 wks
post-STZ. Similarly, the levels of Tyr, Asn, Ser, His, Ala, & Pro showed
progressive increase. Our results indicate that the impaired TCA cycle
metabolites in peripheral nerve is the primary cause of shunting metabolic
substrate to compensatory pathways which leads to mitochondrial dysfunction &
nerve damage.
